- Home
- TSHA vs WABC Comparison
TSHA vs WABC Comparison
Compare TSHA & WABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- WABC
- Stock Information
- Founded
- TSHA 2019
- WABC 1972
- Country
- TSHA United States
- WABC United States
- Employees
- TSHA N/A
- WABC N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- WABC Major Banks
- Sector
- TSHA Health Care
- WABC Finance
- Exchange
- TSHA Nasdaq
- WABC Nasdaq
- Market Cap
- TSHA 1.4B
- WABC 1.2B
- IPO Year
- TSHA 2020
- WABC N/A
- Fundamental
- Price
- TSHA $3.84
- WABC $47.96
- Analyst Decision
- TSHA Strong Buy
- WABC Hold
- Analyst Count
- TSHA 9
- WABC 2
- Target Price
- TSHA $10.22
- WABC $52.00
- AVG Volume (30 Days)
- TSHA 4.1M
- WABC 141.9K
- Earning Date
- TSHA 11-04-2025
- WABC 10-16-2025
- Dividend Yield
- TSHA N/A
- WABC 3.90%
- EPS Growth
- TSHA N/A
- WABC N/A
- EPS
- TSHA N/A
- WABC 4.59
- Revenue
- TSHA $6,310,000.00
- WABC $264,660,000.00
- Revenue This Year
- TSHA N/A
- WABC N/A
- Revenue Next Year
- TSHA N/A
- WABC N/A
- P/E Ratio
- TSHA N/A
- WABC $10.28
- Revenue Growth
- TSHA N/A
- WABC N/A
- 52 Week Low
- TSHA $1.05
- WABC $42.00
- 52 Week High
- TSHA $5.51
- WABC $59.97
- Technical
- Relative Strength Index (RSI)
- TSHA 37.78
- WABC 50.53
- Support Level
- TSHA $3.89
- WABC $46.60
- Resistance Level
- TSHA $4.55
- WABC $47.79
- Average True Range (ATR)
- TSHA 0.39
- WABC 0.87
- MACD
- TSHA -0.19
- WABC 0.06
- Stochastic Oscillator
- TSHA 8.99
- WABC 57.69
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About WABC Westamerica Bancorporation
Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.